# Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects

> **NCT02341183** · NA · WITHDRAWN · sponsor: **University of North Carolina, Chapel Hill**

## Conditions studied

- COPD
- Chronic Bronchitis

## Interventions

- **DEVICE:** tPAD
- **DEVICE:** 7% hypertonic saline (510K approved as a device)

## Key facts

- **NCT ID:** NCT02341183
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02341183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02341183, "Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02341183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*